Search research articles
Contact Us
Filters
Showing results (641-650 of 764) with videos related to
Page
of 77
Sort By:
Cell Reports. Medicine
|
April 8, 2023
USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable therapeutic vulnerabilities
Naiara Perurena, Rebecca Lock, Rachel A Davis, et al.
Cancer Cell
|
October 6, 2009
Proteomic and genetic approaches identify Syk as an AML target
Cynthia K Hahn, Jacob E Berchuck, Kenneth N Ross, et al.
The Journal of Clinical Investigation
|
February 14, 2012
The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia
Versha Banerji, Stacey M Frumm, Kenneth N Ross, et al.
Plos Genetics
|
November 19, 2010
Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis
Mark M Pomerantz, Yashaswi Shrestha, Richard J Flavin, et al.
The Journal of Clinical Investigation
|
November 4, 2014
Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth
Thanh U Barbie, Gabriela Alexe, Amir R Aref, et al.
Nature Biotechnology
|
January 21, 2022
Massively parallel phenotyping of coding variants in cancer with Perturb-seq
Oana Ursu, James T Neal, Emily Shea, et al.
Nature Biotechnology
|
October 18, 2022
Author Correction: Massively parallel phenotyping of coding variants in cancer with Perturb-seq
Oana Ursu, James T Neal, Emily Shea, et al.
Cancer Research
|
June 29, 2017
PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
Jessie Hao-Ru Hsu, Benjamin Hubbell-Engler, Guillaume Adelmant, et al.
Science Signaling
|
December 19, 2023
RHOA<sup>L57V</sup> drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling
Antje Schaefer, Richard G Hodge, Haisheng Zhang, et al.
JCI Insight
|
August 30, 2022
VRK1 as a synthetic lethal target in VRK2 promoter-methylated cancers of the nervous system
Jonathan So, Nathaniel W Mabe, Bernhard Englinger, et al.
Page
of 77
Search research articles
Search
Showing results (641-650 of 764) with videos related to
Sort By:
Page
of 77
Cell Reports. Medicine
|
April 8, 2023
USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable therapeutic vulnerabilities
Naiara Perurena, Rebecca Lock, Rachel A Davis, et al.
Cancer Cell
|
October 6, 2009
Proteomic and genetic approaches identify Syk as an AML target
Cynthia K Hahn, Jacob E Berchuck, Kenneth N Ross, et al.
The Journal of Clinical Investigation
|
February 14, 2012
The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia
Versha Banerji, Stacey M Frumm, Kenneth N Ross, et al.
Plos Genetics
|
November 19, 2010
Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis
Mark M Pomerantz, Yashaswi Shrestha, Richard J Flavin, et al.
The Journal of Clinical Investigation
|
November 4, 2014
Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth
Thanh U Barbie, Gabriela Alexe, Amir R Aref, et al.
Nature Biotechnology
|
January 21, 2022
Massively parallel phenotyping of coding variants in cancer with Perturb-seq
Oana Ursu, James T Neal, Emily Shea, et al.
Nature Biotechnology
|
October 18, 2022
Author Correction: Massively parallel phenotyping of coding variants in cancer with Perturb-seq
Oana Ursu, James T Neal, Emily Shea, et al.
Cancer Research
|
June 29, 2017
PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
Jessie Hao-Ru Hsu, Benjamin Hubbell-Engler, Guillaume Adelmant, et al.
Science Signaling
|
December 19, 2023
RHOA<sup>L57V</sup> drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling
Antje Schaefer, Richard G Hodge, Haisheng Zhang, et al.
JCI Insight
|
August 30, 2022
VRK1 as a synthetic lethal target in VRK2 promoter-methylated cancers of the nervous system
Jonathan So, Nathaniel W Mabe, Bernhard Englinger, et al.
Page
of 77